T1	Participants 108 145	patients with gastrointestinal cancer
T2	Participants 384 454	leucocyte-depleted (LD) blood in patients with gastrointestinal cancer
T3	Participants 747 788	512 patients with gastrointestinal cancer
T4	Participants 937 988	243 patients received perioperative RBC transfusion
T5	Participants 832 878	89.2 per cent of patients had a primary tumour
T6	Participants 883 935	79.7 per cent underwent surgery with curative intent
T7	Participants 1435 1472	patients with gastrointestinal cancer
